Artificial sweeteners: Dubai’s sugar-free question
TL;DR: Artificial sweeteners are not a proven long-term weight-control strategy, according to the World Health Organization's conditional guidance, but that is not the same as a blanket safety ban.
Key takeaways
- The WHO recommendation on non-sugar sweeteners advises against using them for weight control or reducing noncommunicable disease risk.
- Stevia and its derivatives are included in the WHO's non-sugar sweetener category, despite their plant origin.
- The recommendation excludes people with pre-existing diabetes and does not cover sugar alcohols, as the WHO's explanation of its scope makes clear.
- The guideline's official overview says it does not replace safety assessments or established intake limits for individual sweeteners.
What does the WHO actually say about artificial sweeteners?
The WHO advises against using non-sugar sweeteners as a strategy for controlling body weight or reducing the risk of noncommunicable diseases, such as cardiovascular disease. Its explanation of the recommendation bases that position on a systematic review which did not establish a long-term benefit in reducing body fat in adults or children.
For a reader comparing products in Dubai or elsewhere in the Gulf, the useful distinction is between an ingredient substitution and a promised health outcome. Ask two separate questions: what sweetens this product, and what evidence supports the benefit being advertised? A sugar-free slogan should not be asked to do the work of an entire evidence review. It has quite enough typography to manage already.
The WHO uses the broader term non-sugar sweeteners, rather than only artificial sweeteners. Its list of common examples includes aspartame, acesulfame K, saccharin, sucralose, stevia and stevia derivatives. Those names are useful starting points when reading an ingredients list, not a personal ranking of which product to buy.
Is stevia outside the recommendation because it is natural?
No. Stevia and stevia derivatives are explicitly included in the WHO's definition of non-sugar sweeteners, which covers both synthetic and naturally occurring or modified non-nutritive sweeteners that are not classified as sugars.
That makes the natural-versus-artificial debate a poor shortcut for understanding this particular guideline. For a café order in Dubai, a supermarket purchase in Abu Dhabi or an online grocery basket elsewhere in the GCC, identify the ingredient first. Then check whether the claim concerns sweetness, weight control or safety. Those are different questions, even when the packaging puts them next to the same leaf illustration.
Does this mean artificial sweeteners are banned or unsafe?
No. This guideline is about their use for weight control and disease-risk reduction, not a blanket finding that every sweetener is unsafe. The official WHO guideline overview states that its guidance is not based on toxicological safety assessments and does not update or replace safe or maximal intake levels established by the relevant expert bodies.
Equally, that distinction is not a declaration that every product or intake level is suitable for everyone. The guideline cannot provide personal clearance for a specific ingredient, dose or medical situation. Reading a population recommendation as an individual permission slip would be another leap beyond its scope.
Why is the recommendation conditional?
It is conditional because important uncertainties affect interpretation of the evidence. The WHO's explanation of that qualification says observed links between sweeteners and disease outcomes may be confounded by participants' baseline characteristics and complicated patterns of sweetener use.
In plain English, people who consume more sweeteners may differ from other people in ways that also affect their health. An observed association therefore does not, by itself, establish that the sweetener caused the outcome. The WHO's conditional wording matters: it is neither proof of harm to a particular person nor proof of a long-term benefit.
For UAE readers, the sensible editorial test is whether a headline preserves that uncertainty. Both miracle-substitute marketing and sweeping alarm can outrun what this guidance establishes. Neither becomes more scientific with a dramatic photograph.
Do diabetes and sugar alcohols need separate consideration?
Yes. People with pre-existing diabetes are excluded from this recommendation, and sugar alcohols, also called polyols, are outside its scope. The WHO's scope statement also excludes personal-care and hygiene products and medications containing these sweeteners.
Exclusion is not a recommendation for or against their use in those circumstances. This article does not translate the general guidance into a diabetes-management plan or advice to change medicines, food or drink intake. Individual questions belong with a qualified healthcare professional who can consider the person's circumstances.
What should a UAE shopper take from this?
Keep the ingredient question, the benefit claim and the personal-suitability question separate. A useful comparison note records the named sweetener, the exact benefit claimed and whether the evidence actually addresses that benefit. That is a reading framework, not a prescribed dietary change.
If the product is an energy drink, our separate guide to reading caffeine, sugar and pack information covers that different label-reading task. This article addresses sweetener evidence, not caffeine allowances or energy-drink suitability.
Limitations
This is an explanation of a population-level WHO recommendation, not an assessment of every sweetener or every UAE product. It does not establish an individual's disease risk, explain symptoms, assess mitochondrial function or show that a wellness test can identify the effects of a particular sweetener.
The distinction between weight-control guidance and ingredient safety is central. The WHO guideline overview explicitly separates its purpose from toxicological assessments. The recommendation's exclusions and conditional status also limit how far its conclusions can be applied.
Where does mescreen™ fit?
mescreen™ offers a separate wellness profiling service, not an answer to whether a particular sweetener suits you. The current UAE product page describes an at-home mitochondrial function assessment using a dried blood spot sample and laboratory analysis, with a non-diagnostic report for wellbeing and performance tracking. It states that the service is not intended to diagnose, treat or cure a medical condition.
If you are exploring wellness tracking for its own purposes, review that service description and its limits before deciding whether it matches your goal. A sweetener question alone is not a reason this article recommends buying a test.